info@efcni.org

Other content tagged: RSV

Platinum Partner AstraZeneca produced and funded “Sounds of RSV” to support awareness of symptoms

  Our partnership with AstraZeneca is part of the EFCNI’s ongoing dedication to raising awareness amongst parents and healthcare professionals about the symptoms of RSV infection and how it can be prevented. With around 33 million acute lower respiratory infections caused each year, RSV infection is one of the most common causes of early life wheezing illness.[1,2] Babies who are born prematurely or who have underlying health issues such as heart or…
Read more

FIRST EXPERT ROUNDTABLE ON RSV PROTECTION FOR ALL INFANTS

In 2021, the season of respiratory syncytial virus (RSV) infections was exceptional in terms of the very early onset and the enormously high numbers of hospitalised children. Thus, the last season showed very clearly: RSV is a major health threat to children under two years of age. In most cases of RSV, children develop only mild, cold-like symptoms. However, a number of children suffer from a severe course of the infection with severe respiratory distress and accompanying symptoms that need…
Read more

The impact of childhood RSV infection on children’s and parents’ quality of life

A Spanish study explored the loss of health-related quality of life (HRQoL) in children younger than two years after a respiratory syncytial virus (RSV) infection. Results showed an HRQoL loss of 38%, 32% and 9% during the first, second and third week after the diagnosis and a median cost of ~€600 per treated child. This type of socioeconomic evaluation could help prioritise the development of an RSV vaccine. The Respiratory Syncytial Virus (RSV) is a…
Read more

EFCNI Welcomes Platinum Partner AstraZeneca to Raise Awareness of RSV

    With EFCNI’s long standing leadership in preterm infants’ health and well-being, and AstraZeneca’s heritage in the RSV space, this partnership aims to increase awareness and educate parents and healthcare providers about the signs and symptoms of this challenging condition and available preventative options. In celebration of EFCNI’s platinum partnership with AstraZeneca, we had the opportunity to sit down with three leaders from AstraZeneca’s RSV team to ask about their work within the disease area. RSV is a very common,…
Read more

Fachgesellschaften empfehlen vorgezogene RSV-Prophylaxe nach untypischem Fallanstieg von Kindern mit RSV-bedingten Atemwegsinfektionen

Durch COVID-19-Hygienemaßnahmen und Kontaktbeschränkungen wurden bekannte Grippe- und Erkältungskrankheiten im vergangenen Herbst und Winter zurückgedrängt. Nach Lockerungen der Schutz- und Hygieneregeln nehmen nun auch andere Atemwegsinfektionen wieder zu. Ärzte beobachten derzeit besorgt einen für die Jahreszeit untypischen, verfrühten Anstieg an Krankenhausaufnahmen mit einer hohen Belastung der Kinderkliniken durch Atemwegsinfektionen aufgrund des Respiratorischen Synzytial Virus (RSV). Üblicherweise verläuft die RSV-Saison in Deutschland parallel zu anderen Atemwegsinfekten in den Wintermonaten zwischen November und April. Das RSV ist vor allem für Frühgeborene und Kleinkinder gefährlich,…
Read more

Parental knowledge of respiratory infections in preterm infants

A survey among parents regarding their understanding of respiratory syncytial virus (RSV) and other respiratory infections in preterm babies showed a highly established knowledge. Most parents consider RSV illness a very serious condition and identified nurses, doctors, and pamphlets as their primary sources of information. The Canadian Premature Babies Foundation (CPBF), a parent-led organisation, strives to minimise the overwhelming challenges of families of preterm babies through the provision of evidence-based information. These educational mandates,…
Read more

Promising new research findings in the field of RSV prevention

Respiratory Syncytial Virus (RSV) has long been recognised as a serious threat to infant health. RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs). No prevention exists for all infants. Research published earlier this year now suggests that a new preventative option may be able to lower severe RSV infection and hospitalisations. Particularly common during the winter months, RSV infects the lungs…
Read more

Roundtable workshop with parent representatives

Sharing knowledge and experience is key. That is why, on June 28-29, Silke Mader, Dr Johanna Walz and Dr Silvia Kolossa from EFCNI held a workshop on “How to organise an expert roundtable” with 15 international parent representatives. While the Friday was filled with shared experiences on roundtables and insights on project management, the workshop on Saturday focused on the set up of an expert roundtable. The specific topics covered were: • Project management…
Read more

RSV – a respiratory virus that can become dangerous for preterm babies

Interview with Prof Luc J.I. Zimmermann Prof. Zimmermann, in adults, how does a typical course of infection with RSV look like and how frequent is it? RSV infections are very common, and, just like the influenza virus, RSV appears during flu season, in the coldest and wettest months of the year. In healthy adults, an RSV infection shows only mild symptoms similar to the common cold, like a running nose or a sore throat, and normally does not need to…
Read more